Search

everythinglearnresearchcommunity

for

Search:↓

A model called PM-DBiGRU was developed for analyzing sentiments in drug reviews, and it performed better than other models, but struggled with complex sentences and situations requiring background knowledge.

Nanoemulsions with minoxidil and clove oil effectively target hair follicles for better alopecia treatment.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Hair loss can cause emotional and social issues, and various treatments, including medication, surgery, and psychological support, are needed.

Minoxidil may protect nerves and improve hair quality during paclitaxel treatment.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Minoxidil dissolves better in propylene glycol + water than in supercritical CO2.

Changing allopregnanolone levels in baby rats affects their adult behavior and alcohol use.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Microemulsions could improve skin drug delivery but face challenges like complex creation and potential toxicity.

Transepidermal drug delivery effectively treated areata alopecia with minimal side effects.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Nanoparticle-based drug delivery to hair follicles is more effective when tested under conditions that match skin behavior.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Polymeric nanohydrogels show potential for skin drug delivery but have concerns like toxicity and regulatory hurdles.

Solidified SEDDS improve drug stability and bioavailability better than liquid SEDDS.

Hair analysis is promising for detecting drug misuse in livestock.

Tadalafil and Finasteride may help treat aggressive melanoma.

Potential new drugs for treating PCOS were identified.

Alkylation of human hair keratin allows for adjustable drug release rates in hydrogels for medical use.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Nanocarriers can improve the effectiveness of herbal medicines in treating colorectal cancer.